TRPV2 and cancer: The implication of TRPC5 in the progression and chemoresistance of various cancers (He and Ma, 2016; Yu et al., 2024) suggests, as in the case of TRPV2, that studying the effects of astringents on these channels may have important implications for oral oncology.